Engineers Gate Manager LP Regeneron Pharmaceuticals, Inc. Transaction History
Engineers Gate Manager LP
- $7.46 Billion
- Q2 2025
A detailed history of Engineers Gate Manager LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 30,029 shares of REGN stock, worth $17.4 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
30,029
Previous 27,334
9.86%
Holding current value
$17.4 Million
Previous $17.3 Million
9.06%
% of portfolio
0.21%
Previous 0.31%
Shares
25 transactions
Others Institutions Holding REGN
# of Institutions
1,434Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.46 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.28 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.8 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.22 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...